Obesity is associated with heightened risk of cardiovascular diseases, diabetes, and cancers, as well as increased all-cause mortality. Mississippi consistently ranks among the states with the highest rates of obesity, particularly among African Americans. The University of Mississippi Medical Center has a history of success in basic research, including obesity research, and observational studies, but historically has not been strong in clinical or translational research. This application describes a proposed Mississippi Center for Clinical and Translational Research (CCTR), which will be a partnership involving UMMC, the University of Southern Mississippi, and Tougaloo College, a historically black college/university. The CCTR will also pursue extensive collaboration with the IDeA-funded Louisiana Clinical and Translational Science Center, and Mayo Clinic's Center for Clinical and Translational Science. An Administrative Core with clear lines of authority and responsibility will be responsible for managing and coordinating the full range of CCTR activities. It will monitor progress toward project goals and milestones, and will have a flexible and responsible leadership and advisory structure that will allow it to realign resources to maximize the beneficial effects of the CCTR. A Community Advisory Board will provide bi-directional communication and guidance on community values, concerns, and needs, and will represent the CCTR to Mississippi communities. A Professional Development Core will offer structured mentorship, protected time for research, and substantial funding for obesity-focused research to junior faculty of all CCTR partners, and will offer training and support for community engaged research to develop the next generation of obesity investigators in Mississippi and increase the diversity of the research workforce. A Clinical Research, Epidemiology, and Biostatistics Core will provide extensive training and assistance with research design and implementation, data collection and management, data analysis, biostatistics, and epidemiology to increase the effectiveness, efficiency, and success of clinical and translational obesity research by CCTR faculty members. A Pilot Projects Program will support research projects that are likely to lead to extramural funding and sustained research success, and to improve obesity, related disorders, and health disparities. A Research Service Center will provide ethics consultation and extensive training and assistance with regulatory and administrative management and research implementation. A Tracking and Evaluation Core will provide extensive, accurate, and timely information on CCTR performance and impact to inform project planning and implementation by CCTR leadership and advisory bodies. By realizing the intentions stated above, the CCTR will develop a powerful and sustainable research enterprise that will have an important public health impact by reducing obesity and its complications and health disparities in Mississippi.

Public Health Relevance

Obesity is associated with an increased risk of heart and blood vessel diseases, diabetes, cancer, and other disorders, and may contribute to nearly three million deaths per year, worldwide. Since 1980, rates of obesity in the United States have increased greatly, and Mississippi typically has among the highest rates of obesity in the nation, particularly among African Americans. We are proposing to establish a research center that will focus on obesity, studying questions from basic biology to issues of diet and lifestyle, and seeking treatments, including efforts to change diet and exercise habits that can help reduce obesity and the problems it causes, and also reduce racial and ethnic disparities related to obesity.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54GM115428-05
Application #
10009382
Study Section
Special Emphasis Panel (ZGM1)
Program Officer
Gao, Hongwei
Project Start
2016-08-18
Project End
2021-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
5
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Mississippi Medical Center
Department
Physiology
Type
Schools of Medicine
DUNS #
928824473
City
Jackson
State
MS
Country
United States
Zip Code
39216
Muntner, Paul; Carey, Robert M; Gidding, Samuel et al. (2018) Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline. Circulation 137:109-118
Torres, Elisa R (2018) Validation of the Lifetime Total Physical Activity Questionnaire (LTPAQ) in midlife and older adults with a history of late-onset depression. Arch Psychiatr Nurs 32:580-584
Ma, Yonggang; Mouton, Alan J; Lindsey, Merry L (2018) Cardiac macrophage biology in the steady-state heart, the aging heart, and following myocardial infarction. Transl Res 191:15-28
do Carmo, Jussara M; da Silva, Alexandre A; Freeman, John Nathan et al. (2018) Neuronal Suppressor of Cytokine Signaling 3: Role in Modulating Chronic Metabolic and Cardiovascular Effects of Leptin. Hypertension 71:1248-1257
Benson, Tyler W; Weintraub, Daniel S; Crowe, Matthew et al. (2018) Deletion of the Duffy antigen receptor for chemokines (DARC) promotes insulin resistance and adipose tissue inflammation during high fat feeding. Mol Cell Endocrinol 473:79-88
Hong, Jaeyoung; Hatchell, Kathryn E; Bradfield, Jonathan P et al. (2018) Transethnic Evaluation Identifies Low-Frequency Loci Associated With 25-Hydroxyvitamin D Concentrations. J Clin Endocrinol Metab 103:1380-1392
Raffield, Laura M; Ellis, Jaclyn; Olson, Nels C et al. (2018) Genome-wide association study of homocysteine in African Americans from the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Coronary Artery Risk in Young Adults study. J Hum Genet 63:327-337
Emdin, Connor A; Khera, Amit V; Klarin, Derek et al. (2018) Phenotypic Consequences of a Genetic Predisposition to Enhanced Nitric Oxide Signaling. Circulation 137:222-232
Floyd, J S; Sitlani, C M; Avery, C L et al. (2018) Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group. Pharmacogenomics J 18:127-135
Seyerle, A A; Sitlani, C M; Noordam, R et al. (2018) Pharmacogenomics study of thiazide diuretics and QT interval in multi-ethnic populations: the cohorts for heart and aging research in genomic epidemiology. Pharmacogenomics J 18:215-226

Showing the most recent 10 out of 102 publications